Stories

The IRE Resource Center is a major research library containing more than 27,000 investigative stories.

Most of our stories are not available for download but can be easily ordered by contacting the Resource Center directly at 573-882-3364 or rescntr@ire.org where a researcher can help you pinpoint what you need.

Search results for "drug" ...

  • Almost Forbidden

    As vaping-related youth nicotine addiction surged across the United States, we exposed a key political decision to ignore the clear warning signs years before the crisis. Government documents obtained by the Los Angeles Times revealed that, four years ago, the Food and Drug administration attempted to ban vaping flavors that were hooking young teenagers to nicotine. But after a deluge of over 100 lobbyists visited the White House, senior political officials overruled experts at the FDA and eliminated the flavor ban, along with much of the scientific evidence calling for it. Later that year, the national youth vaping rate skyrocketed.
  • The Opioid Files

    The Opioid Files for the first time identified not only the counties flooded with the highest amount of prescription opioid pills at the height of the prescription drug crisis, but the specific manufacturers, distributors and pharmacies that were responsible for bringing those pills into communities. The Post found that over a seven-year period from 2006-2012, over 76 billion pills of hydrocodone and oxycodone were shipped to pharmacies across the country, more than enough for one pill per person in some communities. The Post also found that opioid death rates tracked with the rates of pills being shipped into those counties. And The Post identified counties and pharmacies with suspicious patterns and large amounts of pain pills. In making the data available by county- and pharmacy-level, The Post gave reporters from across the country the opportunity to write stories about their own communities and the impact that pills had on them.
  • Cops and Robbers

    This series charts the path of perhaps the most corrupt officer to wear a Baltimore Police badge, from his history of ignored complaints of abuse and untruthfulness to showing the depths of crimes uncovered by a federal investigation, including drug trafficking and robbery. The story maps out how the corruption was not an isolated event confined to a particular unit, but rather ingrained in the culture of “plainclothes” police units long relied on to combat crime. It exposes new allegations, and educates readers who might otherwise not understand the negative effects of aggressive policing employed in Baltimore’s most high-crime neighborhoods.
  • Bottle of Lies: The Inside Story of the Generic Drug Boom

    The widespread use of generic drugs has been hailed as one of the most important public health developments of the twenty-first century. Today, 90 percent of the U.S. pharmaceutical market is comprised of generic drugs, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Bottle of Lies: The Inside Story of the Generic Drug Boom exposes for the first time the endemic fraud behind generic drug manufacturing –and the attendant risks for global public health.The narrative investigation interweaves the stories of a determined whistleblower, an intrepid FDA investigator and drug manufacturers determined to deceive regulators. Reported on four continents over a ten-year period, and drawing on 20,000 pages of confidential FDA documents, the book uncovers how one of the world’s greatest public health innovations also became one of its most astonishing swindles. Bottle of Lies uncovers a global industry where companies routinely falsify quality data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects.
  • WaPo: The Opioid Files

    The Opioid Files for the first time identified not only the counties flooded with the highest amount of prescription opioid pills at the height of the prescription drug crisis, but the pharmacies that were specifically responsible for bringing those pills in. The Post found that over a seven-year period from 2006-2012, over 76 billion pills of hydrocodone and oxycodone were shipped to pharmacies across the country, in some places more than enough for one pill per person per day in some communities. The Post also found that opioid death rates tracked quite well with the rates of pills being shipped into those counties. And The Post identified counties and pharmacies with suspicious patterns and amounts of pills. In making the data available in county- and pharmacy-level chunks, The Post allowed reporters from other organizations across the country to write stories about their own communities and the impact that pills had on them.
  • The Implant Files

    For decades, the U.S. Food and Drug Administration’s medical-device approval system has allowed defective implants to spill onto the market, like contaminated water from a broken pipe. Many of those products have remained on hospital shelves, and in patient bodies, long after problems were known. On Sunday, November 25, 2018, the International Consortium of Investigative Journalists, the Associated Press, the NBC News investigative unit and partners around the world published a yearlong investigation that shows regulators bowing to industry pressure to rush approvals, lower safety standards and cloak critical information, and the consequences: a string of grisly accidents that have left hundreds of thousands disfigured, disabled or dead.
  • Medicaid, Under the Influence

    Medicaid, Under the Influence: A joint investigation by the Center for Public Integrity and NPR showed how the pharmaceutical industry has infiltrated nearly every part of the often opaque process that determines how their drugs will be covered by taxpayers.
  • Kaiser Health News: Liquid Gold

    Doctors across the U.S. are becoming millionaires by setting up private, on-site labs and testing urine samples for legal and illegal drugs. The simple tests are costing the U.S. government and American insurers $8.5 billion a year -- more than the entire budget of the Environmental Protection Agency, a groundbreaking investigation by Kaiser Health News showed. Doctors are testing patients - even the elderly - for opioids as well as street drugs like PCP or cocaine that almost never turn up positive. And the payoff is stunning: Testing a tiny cup of urine can bring in thousands of dollars – up to $17,000 in some cases. Yet there are no national standards for who gets tested, for what, or how often.
  • CNN Exclusive: The more opioids doctors prescribe, the more money they make

    As tens of thousands of Americans die from prescription opioid overdoses each year, an exclusive analysis by CNN and researchers at Harvard University found that opioid manufacturers are paying physicians huge sums of money -- and the more opioids a doctor prescribes, the more money he or she makes. In 2014 and 2015, opioid manufacturers paid hundreds of doctors across the country six-figure sums for speaking, consulting and other services. Thousands of other doctors were paid over $25,000 during that time. Physicians who prescribed particularly large amounts of the drugs were the most likely to get paid.
  • WEWS-TV: Prescription for Failure

    In the last two decades, prescription opioids have taken an unrelenting hold on Ohio. The opioid crisis has claimed the lives of thousands of users, landing Ohio on a top five list no one wants to be on: the most opioid-related overdose deaths in the country. For years, media across the country and the state have reported about the devastating impacts of the crisis, but during its exclusive investigation, the WEWS 5 On Your Side Investigative team was the first to uncover the “why.” The team spent six months tracing the opioid crisis to its beginning as well as examining how the state medical board, the group charged with regulating doctors, played a role.